rediff News http://www.rediff.com/tags/ipf India's largest news and entertainment service online.. en-us Thu, 30 Oct 14 19:08:19 +0000 Thu, 30 Oct 14 19:08:19 +0000 http://www.rediff.com/push Rediff feeds Copyright: (C) 2009 Rediff.com India Limited. All Rights Reserved. <![CDATA[Protests in Assam over 'pact' with ultras ]]> http://www.rediff.com/news/report/protests-in-assam-over-pact-with-ultras/20121005.htm Fri, 31 Oct 2014 00:38:19 +0530 <![CDATA[FMC wants investor protection fund]]> http://www.rediff.com/money/report/commission-tells-bourses-to-create-investor-protection-fund/20110817.htm Fri, 31 Oct 2014 00:38:19 +0530 <![CDATA[Bengal Opp. sending wrong message: Min]]> http://www.rediff.com/money/report/bengal-opp-sending-wrong-message-min/20101118.htm Fri, 31 Oct 2014 00:38:19 +0530 <![CDATA[Column: Educating Kapil]]> http://www.rediff.com/money/column/guest-educating-kapil/20100322.htm Fri, 31 Oct 2014 00:38:19 +0530 <![CDATA[Govt plans investor protection fund]]> http://www.rediff.com/money/report/fund/20060825.htm Fri, 31 Oct 2014 00:38:19 +0530 <![CDATA[PFC venture fund plans hit]]> http://www.rediff.com/money/report/pfc/20050707.htm Fri, 31 Oct 2014 00:38:19 +0530 <![CDATA[Stratasys 3D Printing Technology Helps Top Special Effects Company Secure Leading Rolein Guardians of the Galaxy]]> http://in.advfn.com/p.php?pid=nmona&article=64211630 Fri, 31 Oct 2014 00:38:19 +0530 <![CDATA[CHMP recommends label update for Roche's Esbriet in IPF, strengthening mortality benefit and reinforcing safety profile]]> http://www.pharmabiz.com/NewsDetails.aspx?aid=84759&sid=2 Fri, 31 Oct 2014 00:38:19 +0530 <![CDATA[U.S. Centers for Disease Control and Prevention (CDC) Supports Recruitment for MediciNova's Clinical Trial of MN- 166 (Ibudilast) in ALS]]> http://www.bizwireexpress.com/showstoryGNW.php?storyid=47306 Fri, 31 Oct 2014 00:38:19 +0530 <![CDATA[MediciNova Announces FDA Granted Orphan Drug Designation to MN-001 (tipelukast) for Idiopathic Pulmonary Fibrosis (IPF)]]> http://www.bizwireexpress.com/showstoryGNW.php?storyid=47090 Fri, 31 Oct 2014 00:38:19 +0530 <![CDATA[Boehringer Ingelheim initiates global Phase III study investigating nintedanib* in patients with colorectal cancer refractory to standard treatments]]> http://businesswireindia.com/news/news-details/boehringer-ingelheim-initiates-global-phase-iii-study-investigating-ni/41187 Fri, 31 Oct 2014 00:38:19 +0530